XXXX of the ovary: a review of 41 cases and risk factors for recurrence.

@entity1 @entity43 @entity2971 @entity44 @entity1466 @entity957 @entity2970 @entity5 @entity189 @entity5000
OBJECTIVE: To review the outcome of treatment in @entity1 with @entity43 and to define the risk factors for recurrence. MATERIAL AND METHODS: Forty-one @entity1 with @entity43 were reviewed retrospectively. Survival time and survival rate were obtained. Risk factors such as stage, histological type, and type of operation were evaluated for reccurrence. RESULTS: Twenty-three (56%) had @entity5000 , eight (19.5%) had mixed @entity2971 , three (7.3%) had @entity2970 , three (7.3%) had @entity44 teratomas, two (4.8%) had @entity957 arising from a mature @entity44 , one (2.4%) had @entity189 and one @entity1466 . Most of the cases (73%) were in Stage I. Twenty-nine @entity1 (70.7%) underwent conservative surgery and 12 @entity1 (29.3%) had at least bilateral salpingo-oophorectomy. Thirty @entity1 were operated on optimally with surgical staging and 11 suboptimally. Seven @entity1 (17%) had recurrence after remission. The overall survival time was 187 +/- 8.43 months for all cases, 195 +/- 8.49 for @entity5000 and 161 +/- 10.96 for non- @entity5000 cases with a median follow-up time of 98.52 (8-204) months. Non- @entity5000 histologic type, being operated on suboptimally and radically, and advanced @entity5 stage have been found to be risk factors for recurrence. CONCLUSION: Regardless of histologic types and stages the prognosis of @entity2971 are satisfactory with current therapeutic strategies.
